Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.6
(0.0%)
HKD 5.6
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.51 Billion CNY | -10.34% |
| 2022 | 3.91 Billion CNY | 6.37% |
| 2021 | 3.68 Billion CNY | -0.56% |
| 2020 | 3.7 Billion CNY | 11.31% |
| 2019 | 3.32 Billion CNY | 6.6% |
| 2018 | 3.11 Billion CNY | 15.79% |
| 2017 | 2.69 Billion CNY | 1.92% |
| 2016 | 2.64 Billion CNY | 5.4% |
| 2015 | 2.5 Billion CNY | 7.49% |
| 2014 | 2.33 Billion CNY | 13.68% |
| 2013 | 2.05 Billion CNY | 10.87% |
| 2012 | 1.85 Billion CNY | 47.58% |
| 2011 | 1.25 Billion CNY | 22.38% |
| 2010 | 1.02 Billion CNY | 7.2% |
| 2009 | 956.22 Million CNY | 41.72% |
| 2008 | 674.73 Million CNY | 21.8% |
| 2007 | 553.96 Million CNY | 3.86% |
| 2006 | 533.37 Million CNY | -38.16% |
| 2005 | 862.46 Million CNY | -9.74% |
| 2004 | 955.56 Million CNY | 43.02% |
| 2003 | 668.1 Million CNY | 27.72% |
| 2002 | 523.11 Million CNY | 5.48% |
| 2001 | 495.92 Million CNY | 13.53% |
| 2000 | 436.81 Million CNY | -11.46% |
| 1999 | 493.33 Million CNY | 9.46% |
| 1998 | 450.68 Million CNY | 9.52% |
| 1997 | 411.52 Million CNY | -17.84% |
| 1996 | 500.89 Million CNY | 8.07% |
| 1995 | 463.48 Million CNY | 8.21% |
| 1994 | 428.34 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.47 Billion CNY | -0.95% |
| 2024 Q3 | 3.72 Billion CNY | -0.82% |
| 2024 Q2 | 3.75 Billion CNY | 8.12% |
| 2023 FY | 3.51 Billion CNY | -10.34% |
| 2023 Q1 | 3.42 Billion CNY | -12.47% |
| 2023 Q2 | 3.52 Billion CNY | 2.87% |
| 2023 Q4 | 3.51 Billion CNY | 9.0% |
| 2023 Q3 | 3.22 Billion CNY | -8.64% |
| 2022 FY | 3.91 Billion CNY | 6.37% |
| 2022 Q1 | 3.62 Billion CNY | -1.46% |
| 2022 Q4 | 3.91 Billion CNY | -2.15% |
| 2022 Q2 | 3.87 Billion CNY | 6.83% |
| 2022 Q3 | 4 Billion CNY | 3.26% |
| 2021 FY | 3.68 Billion CNY | -0.56% |
| 2021 Q1 | 3.74 Billion CNY | 1.15% |
| 2021 Q2 | 3.74 Billion CNY | 0.09% |
| 2021 Q3 | 3.6 Billion CNY | -3.9% |
| 2021 Q4 | 3.68 Billion CNY | 2.21% |
| 2020 Q4 | 3.7 Billion CNY | 7.23% |
| 2020 Q3 | 3.45 Billion CNY | -5.24% |
| 2020 Q2 | 3.64 Billion CNY | -6.07% |
| 2020 Q1 | 3.87 Billion CNY | 16.63% |
| 2020 FY | 3.7 Billion CNY | 11.31% |
| 2019 FY | 3.32 Billion CNY | 6.6% |
| 2019 Q1 | 3.13 Billion CNY | 0.44% |
| 2019 Q2 | 3.16 Billion CNY | 0.91% |
| 2019 Q3 | 3.03 Billion CNY | -4.14% |
| 2019 Q4 | 3.32 Billion CNY | 9.72% |
| 2018 Q2 | 2.99 Billion CNY | 6.71% |
| 2018 Q3 | 2.97 Billion CNY | -0.75% |
| 2018 FY | 3.11 Billion CNY | 15.79% |
| 2018 Q4 | 3.11 Billion CNY | 4.97% |
| 2018 Q1 | 2.8 Billion CNY | 4.16% |
| 2017 FY | 2.69 Billion CNY | 1.92% |
| 2017 Q4 | 2.69 Billion CNY | -6.02% |
| 2017 Q3 | 2.86 Billion CNY | 3.24% |
| 2017 Q2 | 2.77 Billion CNY | 2.35% |
| 2017 Q1 | 2.71 Billion CNY | 2.63% |
| 2016 FY | 2.64 Billion CNY | 5.4% |
| 2016 Q4 | 2.64 Billion CNY | 3.73% |
| 2016 Q1 | 2.53 Billion CNY | 1.0% |
| 2016 Q2 | 2.38 Billion CNY | -5.66% |
| 2016 Q3 | 2.54 Billion CNY | 6.64% |
| 2015 Q1 | 2.41 Billion CNY | 3.56% |
| 2015 Q4 | 2.5 Billion CNY | -0.02% |
| 2015 FY | 2.5 Billion CNY | 7.49% |
| 2015 Q3 | 2.5 Billion CNY | -1.56% |
| 2015 Q2 | 2.54 Billion CNY | 5.47% |
| 2014 Q1 | 2.04 Billion CNY | -0.17% |
| 2014 Q3 | 2.27 Billion CNY | 8.06% |
| 2014 Q4 | 2.33 Billion CNY | 2.63% |
| 2014 FY | 2.33 Billion CNY | 13.68% |
| 2014 Q2 | 2.1 Billion CNY | 2.68% |
| 2013 Q4 | 2.05 Billion CNY | 8.43% |
| 2013 FY | 2.05 Billion CNY | 10.87% |
| 2013 Q3 | 1.89 Billion CNY | 0.59% |
| 2013 Q2 | 1.88 Billion CNY | -4.42% |
| 2013 Q1 | 1.96 Billion CNY | 6.35% |
| 2012 FY | 1.85 Billion CNY | 47.58% |
| 2012 Q2 | 1.61 Billion CNY | -2.75% |
| 2012 Q1 | 1.66 Billion CNY | 32.48% |
| 2012 Q3 | 1.8 Billion CNY | 11.92% |
| 2012 Q4 | 1.85 Billion CNY | 2.35% |
| 2011 Q2 | 1.09 Billion CNY | 2.15% |
| 2011 FY | 1.25 Billion CNY | 22.38% |
| 2011 Q4 | 1.25 Billion CNY | -6.22% |
| 2011 Q3 | 1.33 Billion CNY | 21.65% |
| 2011 Q1 | 1.07 Billion CNY | 5.02% |
| 2010 Q2 | 1.12 Billion CNY | 6.73% |
| 2010 Q3 | 1.14 Billion CNY | 1.62% |
| 2010 Q4 | 1.02 Billion CNY | -10.18% |
| 2010 Q1 | 1.05 Billion CNY | 10.04% |
| 2010 FY | 1.02 Billion CNY | 7.2% |
| 2009 Q2 | 816.6 Million CNY | 4.41% |
| 2009 FY | 956.22 Million CNY | 41.72% |
| 2009 Q3 | 891.12 Million CNY | 9.12% |
| 2009 Q1 | 782.1 Million CNY | 15.91% |
| 2009 Q4 | 956.22 Million CNY | 7.31% |
| 2008 Q2 | 608.89 Million CNY | 5.31% |
| 2008 FY | 674.73 Million CNY | 21.8% |
| 2008 Q1 | 578.21 Million CNY | 4.38% |
| 2008 Q4 | 674.73 Million CNY | -13.62% |
| 2008 Q3 | 781.15 Million CNY | 28.29% |
| 2007 FY | 553.96 Million CNY | 3.86% |
| 2007 Q3 | 529.62 Million CNY | -9.61% |
| 2007 Q1 | 607.83 Million CNY | 13.96% |
| 2007 Q2 | 585.9 Million CNY | -3.61% |
| 2007 Q4 | 553.96 Million CNY | 4.6% |
| 2006 Q2 | 710.62 Million CNY | -18.25% |
| 2006 Q1 | 869.28 Million CNY | 0.79% |
| 2006 Q4 | 533.37 Million CNY | -34.81% |
| 2006 FY | 533.37 Million CNY | -38.16% |
| 2006 Q3 | 818.16 Million CNY | 15.13% |
| 2005 Q2 | 1.04 Billion CNY | 11.53% |
| 2005 Q4 | 862.46 Million CNY | -7.67% |
| 2005 Q3 | 934.1 Million CNY | -10.92% |
| 2005 Q1 | 940.21 Million CNY | -1.61% |
| 2005 FY | 862.46 Million CNY | -9.74% |
| 2004 Q4 | 955.56 Million CNY | 2.88% |
| 2004 Q1 | 821.97 Million CNY | 23.03% |
| 2004 Q3 | 928.78 Million CNY | -4.05% |
| 2004 FY | 955.56 Million CNY | 43.02% |
| 2004 Q2 | 968.01 Million CNY | 17.77% |
| 2003 FY | 668.1 Million CNY | 27.72% |
| 2003 Q1 | 565.17 Million CNY | 8.04% |
| 2003 Q2 | 601.51 Million CNY | 6.43% |
| 2003 Q3 | 700.95 Million CNY | 16.53% |
| 2003 Q4 | 668.1 Million CNY | -4.69% |
| 2002 Q3 | 500.89 Million CNY | 2.12% |
| 2002 Q1 | 521.17 Million CNY | 5.09% |
| 2002 FY | 523.11 Million CNY | 5.48% |
| 2002 Q2 | 490.49 Million CNY | -5.89% |
| 2002 Q4 | 523.11 Million CNY | 4.43% |
| 2001 Q4 | 495.92 Million CNY | 0.0% |
| 2001 Q2 | 447.71 Million CNY | 0.0% |
| 2001 FY | 495.92 Million CNY | 13.53% |
| 2000 FY | 436.81 Million CNY | -11.46% |
| 2000 Q4 | 436.81 Million CNY | 0.0% |
| 2000 Q2 | 533.31 Million CNY | 0.0% |
| 1999 FY | 493.33 Million CNY | 9.46% |
| 1999 Q4 | 493.33 Million CNY | 0.0% |
| 1999 Q2 | 503.43 Million CNY | 0.0% |
| 1998 Q4 | 450.68 Million CNY | 0.0% |
| 1998 FY | 450.68 Million CNY | 9.52% |
| 1998 Q2 | 414.37 Million CNY | 0.0% |
| 1997 Q4 | 411.52 Million CNY | 0.0% |
| 1997 FY | 411.52 Million CNY | -17.84% |
| 1997 Q2 | 463.5 Million CNY | 0.0% |
| 1996 FY | 500.89 Million CNY | 8.07% |
| 1996 Q4 | 500.89 Million CNY | 0.0% |
| 1995 FY | 463.48 Million CNY | 8.21% |
| 1994 FY | 428.34 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 142.28 Million HKD | -2367.222% |
| Grand Pharmaceutical Group Limited | 7.24 Billion HKD | 51.546% |
| Extrawell Pharmaceutical Holdings Limited | 170.4 Million HKD | -1960.017% |
| Wai Yuen Tong Medicine Holdings Limited | 709.65 Million HKD | -394.665% |
| Qianhai Health Holdings Limited | 94 Million HKD | -3634.363% |
| Lee's Pharmaceutical Holdings Limited | 930.06 Million HKD | -277.436% |
| Essex Bio-Technology Limited | 903.78 Million HKD | -288.414% |
| Tongfang Kontafarma Holdings Limited | 665.38 Million HKD | -427.573% |
| PuraPharm Corporation Limited | 689.65 Million HKD | -409.013% |
| SSY Group Limited | 4.49 Billion HKD | 21.885% |
| JBM (Healthcare) Limited | 366.75 Million HKD | -857.16% |
| Jacobson Pharma Corporation Limited | 1.09 Billion HKD | -221.91% |
| China Resources Pharmaceutical Group Limited | 168.46 Billion HKD | 97.916% |